Our Approach
Three integrated technologies that deliver clinical-quality hearing care independent of geography or clinic access.
Ampira softwaresends commands to our factory-calibrated device, delivering pure tones at precise frequencies from 500 Hz through 8 kHz. The system records the user's hearing thresholds and generates a clinical-grade audiogram, then automatically configures the device's amplification curve to match the user's hearing profile.
AI-powered noise suppression isolates speech from background noise and adapts continuously to the acoustic environment. Profile mapping is applied automatically from the audiogram to optimize amplification for real-world listening conditions.
For cases requiring clinical review, Ampira's teleaudiology platform connects patients with licensed audiologists remotely. Expert adjustment and ongoing oversight, at a fraction of the cost of in-person care.
How It Works
The Ampira device arrives ready to use. Open the app, pair via Bluetooth, and place the device in your ear. Setup takes under two minutes.
The app sends test commands to the device. The device delivers factory-calibrated pure tones at precise frequencies from 500 Hz through 8 kHz. The user responds on screen. The system records hearing thresholds across the standard audiometric range.
The user's hearing profile is generated automatically. The audiogram is produced under the same acoustic principles used in professional audiology practice and is comparable to standard clinical booth audiometry.
The app applies the audiogram to configure the device's amplification curve in real time. The hearing aid is fit to the user's specific hearing loss profile. No audiologist is required for first fit.
For users who want clinical review or ongoing adjustment, Ampira's teleaudiology platform connects patients with licensed audiologists at a fraction of the cost of in-clinic care.
Our Advantage
Unlike software-only approaches, Ampira controls both the hardware and the software stack. Every device is factory-calibrated. Every tone delivered is verified. That is what makes the audiogram clinically defensible and what distinguishes Ampira as a medical product rather than a consumer wellness application.
Evidence-Based
Ampira is planning to conduct a prospective clinical study in partnership with the University of Arizona Department of Speech, Language, and Hearing Sciences. The study compares Ampira-generated audiograms to gold-standard calibrated booth audiometry in a real-world quiet environment, with results expected in 2026.
Study Design
Structured comparative validation study
Participant Group
Adults across target user demographics
Validation Goal
Strong alignment with clinical standards
Our Philosophy
Every decision we make, from hardware architecture to pricing, follows the same four principles.
Accuracy lives in the hardware. We build and calibrate every device ourselves because you cannot write software that compensates for a transducer you do not control.
The same device that tests your hearing fits it. Assessment and fitting occur within a single unified system, with no handoffs, no translation errors, and no loss of calibration context.
Every performance claim is backed by a test, a protocol, or a published study. We do not publish numbers we have not validated.
We are designing for the people traditional hearing care has failed to reach, while building a solution refined enough for anyone to want.